Clinical Trial

Efficacy and Safety of CRT, Durvalumab and Surgery for SST

Name: Efficacy and Safety of CRT, Durvalumab and Surgery for SST — clinical trial record (NCT04465968)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DEEP_OCEAN

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The safety and efficacy of multimodality treatment of pre- and post-operative durvalumab therapy after pre-operative chemoradiotherapy for resectable superior sulcus tumor (SST) and durvalumab maintenance therapy after chemoradiotherapy for unresectable SST

Trial Details

NCT Number	NCT04465968
Lead Sponsor	National Cancer Center Hospital East Collaborators: AstraZeneca, Japan Agency for Medical Research and Development, Japan Clinical Oncology Group
Conditions	Superior Sulcus Tumor, Non-small Cell Lung Cancer Stage IIB, Non Small Cell Lung Cancer Stage III
Enrollment	84 participants
Start Date	2020-09-01
Primary Completion	2027-08-31 (estimated)
Study Completion	2030-08-31 (estimated)
Updated on ClinicalTrials.gov	2020-07-10